Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tscan Therapeutics, Inc.

2.48
0.0000
Post-market: 2.45-0.0300-1.21%19:38 EDT
Volume:711.92K
Turnover:1.72M
Market Cap:140.74M
PE:-1.03
High:2.57
Open:2.48
Low:2.28
Close:2.48
52wk High:6.23
52wk Low:1.02
Shares:56.75M
Float Shares:44.03M
Volume Ratio:0.94
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4102
EPS(LYR):-2.2530
ROE:-63.33%
ROA:-26.77%
PB:0.80
PE(LYR):-1.10

Loading ...

Company Profile

Company Name:
Tscan Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
209
Office Location:
830 Winter Street,Waltham,Massachusetts,United States
Zip Code:
02451
Fax:
- -
Introduction:
TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 that is in Phase I clinical trial for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. It also develops TSC-200, TSC-201, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors; and TSC-202 to treat solid tumors. In addition, the company develops vaccines for infectious diseases, such as SARS-CoV-2. It has collaborations with Novartis Institutes for BioMedical Research, Inc. To discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Directors

Name
Position
Gavin MacBeath
Director and Chief Executive Officer
Stephen Biggar
Chair of the Board
Barbara Klencke
Director
Gabriela Gruia
Director
Garry Nicholson
Director
Katina Dorton
Director
R. Keith Woods
Director

Shareholders

Name
Position
Gavin MacBeath
Director and Chief Executive Officer
Jason A. Amello
Chief Financial Officer and Treasurer
Chrystal Louis
Chief Medical Officer
Leiden Dworak
Vice President, Finance and Principal Accounting Officer
Zoran Zdraveski
Chief Legal and Strategy Officer and Secretary